peptic ulcer. gastroduodenal ulcer NOS peptic ulcer NOS
Conditions
Interventions
Intervention 1: Intervention 1 : Capsule Omeprazol 40 miligram(mg) (Osveh Pharmaceutical Company) , Tablet (tab)clarithromycine 1 gram(gr) (Chemidarou Pharmaceutical Company) and capsule amoxicilline
Treatment - Drugs
Intervention 2 : Capsule Omeprazol 40 miligram(mg) (Osveh Pharmaceutical Company) , Tablet (tab)clarithromycine 1 gram(gr) (Chemidarou Pharmaceutical Company) and capsule amoxicilline 2 gr (Kosar Phar
Intervention 1 : Capsule Omeprazol 40 miligram(mg) (Osveh Pharmaceutical Company) , Tablet (tab)clarithromycine 1 gram(gr) (Chemidarou Pharmaceutical Company) and capsule amoxicilline 2 gr (Kosar Phar
Sponsors
Vice chancellor for research, Golestan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients with peptic ulcer in endoscopy and positive rapid urease test for helicobacter pylori (HP) infection are enrolled. Exclusion criteria: Patients that are taking non steroid anti-inflammatory drugs (NSAIDs), proton pump inhibitors (PPIs), bismuth preparations or antibiotics during the last four weeks and with prior HP eradication, glaucoma, prostatic hypertrophy, pregnancy , lactation and intolerable side effects of clidinium-c are excluded.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Helicobacter pylori eradication. Timepoint: Before and 8 weeks after intervention. Method of measurement: Before intervention in antrum sample with rapid urease test and 8 weeks after intervention with urease breathe test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Age. Timepoint: Before intervention. Method of measurement: Year-Birth certificate.;Sex. Timepoint: Before intervention. Method of measurement: Female/male-Observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaba Homapour
Golestan University of Medical Sciences
Outcome results
None listed